What is SetBone Medical?
SetBone Medical is an Israel-based medical technology innovator founded by Nimrod Kaufmann and Royi Kaufmann, PhD. As a key portfolio entity within The Trendlines Group, the company specializes in the development of advanced, next-generation cements designed to outperform current industry standards. The firm operates at the intersection of material science and orthopedic surgery, targeting a market segment valued in excess of $1 billion. By focusing on the development of safer, more efficient bonding agents, SetBone Medical aims to redefine the standard of care in orthopedic procedures, providing clinicians with superior tools that mitigate the risks associated with traditional surgical cements.
How much funding has SetBone Medical raised?
SetBone Medical has raised a total of $1.6M across 1 funding round:
Unspecified
$1.6M
Unspecified (2022): $1.6M with participation from Chicago ArchAngels, The Trendlines Group, and Agriline
Key Investors in SetBone Medical
The Trendlines Group
An investment firm that invents, discovers, and incubates innovation-based medtech and agrifood technologies, providing hands-on support from development to business building.
Chicago ArchAngels
A prominent angel investing group providing risk capital to early-stage companies, leveraging the extensive business experience of its members to foster technological proof of concept.
Agriline
An investment entity participating in the funding round to support the advancement of innovative medical and agricultural technologies.
What's next for SetBone Medical?
With the recent influx of capital, SetBone Medical is poised to scale its research and development operations while simultaneously navigating the complex regulatory pathways required for international market entry. The strategic focus will likely shift toward clinical validation and the expansion of its intellectual property portfolio to maintain a competitive edge in the medtech sector. As the company matures, the emphasis will remain on scaling production capabilities and establishing robust distribution channels to capture significant market share. The ongoing support from its primary backers suggests a long-term commitment to scaling the business, with potential for future strategic partnerships or acquisition opportunities as the technology reaches commercial maturity.
See full SetBone Medical company page
